Hypofractionated concurrent chemoradiation in non-small cell lung cancer (NSCLC): efficacy and toxicity of the SOCCAR trial regime in real world practice

被引：1
|
作者：
Iqbal, M. S. [1 ]
Vashisht, G. [2 ]
Mulvenna, P. [1 ]
McDonald, F. [1 ]
Turnbull, H. [1 ]
Atherton, P. [1 ]
Bradshaw, A. [1 ]
Simmons, T. [3 ]
Kovarik, J. [1 ]
Singhal, S. [1 ]
McMenemin, R. [3 ]
Greystoke, A. [4 ]
机构：
[1] Northern Ctr Canc Care, Clin Oncol, Newcastle Upon Tyne, Tyne & Wear, England
[2] Newcastle Univ, Med Sch, HH, Newcastle Upon Tyne, Tyne & Wear, England
[3] Freeman Rd Hosp, NCCC, Clin Oncol, Newcastle Upon Tyne, Tyne & Wear, England
[4] NCCC, Med Oncol, Newcastle Upon Tyne, Tyne & Wear, England
来源：
LUNG CANCER | 2018年 / 115卷
关键词：
D O I：
10.1016/S0169-5002(18)30175-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
149
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [1] SOCCAR TRIAL: COMPARING TOXICITY AND EFFICACY OF HYPOFRACTIONATED CONCURRENT CHEMORADIATION TO PUBLISHED TRIALS
    O'Rourke, Noelle
    Maguire, Joe
    Mcmenamin, Rhona
    Snee, Michael P.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S495 - S496
  • [2] Oesophageal Toxicity and Hypofractionated Concurrent Chemoradiotherapy for Non-small Cell Lung Cancer
    Tho, L. M.
    Mahmood, R.
    Leitch, M.
    Brisbane, I.
    Kakumanu, S.
    Mohammed, N.
    CLINICAL ONCOLOGY, 2009, 21 (01) : 74 - 74
  • [3] Efficacy and toxicity hypofractionated radiotherapy for centrally located non-small cell lung cancer
    Janjua, Tanzeel
    Sun, Fei
    Clarke, Katy
    Dickinson, Pete
    Franks, Kevin
    Arunsingh, Moses
    Teo, Mark
    Jain, Pooja
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2021, 22
  • [4] Real world efficacy of nivolumab for non-small cell lung cancer (NSCLC) in the West of Scotland (WoS)
    Ansel, S.
    Rulach, R.
    Clark, B.
    Steele, N.
    Maclaren, V.
    LUNG CANCER, 2018, 115 : S35 - S36
  • [5] Efficacy and Toxicity of Different Chemotherapy Protocols for Concurrent Chemoradiation in Non-Small Cell Lung Cancer-A Secondary Analysis of the PET Plan Trial
    Gkika, Eleni
    Lenz, Stefan
    Schimek-Jasch, Tanja
    Waller, Cornelius F.
    Kremp, Stephanie
    Schaefer-Schuler, Andrea
    Mix, Michael
    Kuesters, Andreas
    Tosch, Marco
    Hehr, Thomas
    Eschmann, Susanne Martina
    Bultel, Yves-Pierre
    Hass, Peter
    Fleckenstein, Jochen
    Thieme, Alexander Henry
    Stockinger, Marcus
    Dieckmann, Karin
    Miederer, Matthias
    Holl, Gabriele
    Rischke, Hans Christian
    Adebahr, Sonja
    Koenig, Jochem
    Binder, Harald
    Grosu, Anca-Ligia
    Nestle, Ursula
    CANCERS, 2020, 12 (11) : 1 - 18
  • [6] Real-World Data Comparing Cisplatin/Vinorelbine and Carboplatin/Paclitaxel in Concurrent Chemoradiation for Non-Small Cell Lung Cancer (NSCLC): Safety and Outcomes
    Chan, Christopher Wei En
    Abdelaziz, Noha
    Makady, Nafie Faisal
    LUNG CANCER, 2025, 200
  • [7] CONCURRENT CHEMORADIATION TREATMENT FOR INOPERABLE, NONMETASTASIC, UNFIT NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Pons, F.
    Nadal, E. S.
    Plana, M.
    Palmero, R.
    Sole, J. M.
    Brao, I.
    Castany, R.
    Padrones, S.
    Arnaiz, M. M.
    Cardenal, F.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S75 - S75
  • [8] Concurrent chemoradiation in the management of inoperable non-small cell lung cancer
    Maguire, J
    Page, R
    Kelly, V
    Smith, N
    Ledson, N
    Walshaw, M
    THORAX, 2001, 56 : 68 - 68
  • [9] Toxicity of Hypofractionated Accelerated Radiotherapy Concurrent with Chemotherapy for Non-small Cell Carcinoma of the Lung
    Carruthers, R.
    O'Rourke, N.
    Mohammed, N.
    Hicks, J.
    Brisbane, I.
    CLINICAL ONCOLOGY, 2011, 23 (08) : 561 - 562
  • [10] Predictive factors for survival and toxicity in stage III non-small cell lung cancer with concurrent chemoradiation
    Kim, Y.
    Ahn, S.
    Kim, Y.
    Kim, K.
    Oh, I.
    Chung, W.
    Nam, T.
    Yoon, M.
    Jeong, J.
    Song, J.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S319 - S319
12345